An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Because most of the major risk factors are beyond your control, there’s no proven way to truly reduce ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

For example, androgens attach to special receptors on the surface of prostate cancer cells, which enables the cells to send ...

The American Cancer Society reports that prostate cancer is the second most diagnosed cancer in men across the globe. Each ...

PEOPLE and Verywell Health joined forces to share facts about prostate cancer, plus unique perspectives from men with the disease and their caregiving teams.

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

MetasTx CEO Harvey D. Homan, Ph.D. , a 2022 NJBiz ICON Award honoree, underscored the company’s NJ roots and continuing ties to the Garden State through advisory relationships with Morristown-based ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

This medication is a beneficial addition to your prostate cancer treatment plan — but it doesn’t come without risks. Here’s how to stay ahead of potential side effects. If you’ve been diagnosed with ...